Background Image
 1 / 16 Next Page
Information
Show Menu
1 / 16 Next Page
Page Background

PITUITARY, THYROID&

ADRENALDISORDERS

Adrenal gland tumours linked

to ADHD diagnosis

4

DIABETES

Starting with combination

diabetes therapy beats initial

monotherapy

6

CONFERENCE

ADA 2016

10

Bariatric surgery reduces the

incidence of

retinopathy and

nephropathy in obese

patients with type 2 diabetes

Food order impacts

postprandial glucose

and insulin excursions

significantly

A hybrid closed-loop system

proves safe and e ective

for home use in type 1

diabetes

Metabolic syndrome in

type 1 diabetes is a prelude

to escalating costs and

complications

OBESITY

Trends in obesity

prevalence among

children and

adolescents

14

Diet inclusive of

healthy fats does not

lead to weight gain

15

OPINION

Studies designed

to further

understand the

biology behind

obesity are

necessary to

improve the

treatment of this

deleterious disease

until we design

public health

policies to reverse

part of the toxic

environment.

Dr Eric Ravussin &

Dr Martica Heaner

15

In the two separate SWITCH

1 and 2 trials in types 1 and

2 diabetes, insulin degludec

reduced hypoglycaemia vs

insulin glargine U100.

These results of the SWITCH 1

and 2 trials were reported at the

76th Scientific Sessions of the

American Diabetes Association,

from June 10–14.

3

Insulin degludec

reduced

hypoglycaemia

vs U100 insulin

glargine in

separate trials

in types 1 and 2

diabetes

Long-term e ects of

neighbourhood deprivation on

diabetes risk

The Lancet Diabetes & Endocrinology

This is an interesting study design,

and the results provide further

evidence that socioeconomic

factors are significant contributors to

diabetes risk.

3

Liraglutide reduces CV outcomes in

patients with type 2 diabetes

The New England Journal of Medicine

Liraglutide appears to be superior to

placebo for reducing events

and deaths from cardiovascular

causes in patients with type 2

diabetes.

6

Cardiovascular e ects of SGLT-2

inhibitors in type 2 diabetes

The Lancet Diabetes & Endocrinology

The available data provide a strong

rationale to expect benefit from use

of SGLT2 inhibitors in patients

with type 2 diabetes at high risk of

cardiovascular events

.

8

Portion-controlled prepackaged

foods promote weight loss

Obesity

Overweight and obese patients who

followed meal plans that include

portion-controlled prepackaged

foods lost more weight and fat than

those who followed meal plans

involving self-selection of foods.

15

ISSN 2206-4656

VOL. 1 • No. 1 • 2016

RESEARCH NEWS AND VIEWS FROM ELSEVIER

FORMERLY CLINICAL ENDOCRINOLOGY NEWS